Home LiteratureArticle Details
PMID: 11390999 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse.

Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL, Wilson SB, Sarvetnick N

Abstract

Quantitative and qualitative defects in CD1-restricted natural killer T cells have been reported in several autoimmune-prone strains of mice, including the nonobese diabetic (NOD) mouse. These defects are believed to be associated with the emergence of spontaneous autoimmunity. Here we demonstrate that both CD1d-null NOD and CD1d-null NOD/BDC2.5 T cell receptor transgenic mice have an accelerated onset and increased incidence of diabetes when compared with CD1d(+/-) and CD1d(+/+) littermates. The acceleration of disease did not seem to result from changes in the T helper (Th)1/Th2 balance because lymphocytes purified from lymphoid organs and pancreatic islets of wild-type and CD1d-null mice secreted equivalent amounts of IFN-gamma and IL-4 after stimulation. In contrast, the pancreata of CD1d-null mice harbored significantly higher numbers of activated memory T cells expressing the chemokine receptor CCR4. Notably, the presence of these T cells was associated with immunohistochemical evidence of increased destructive insulitis. Thus, CD1d-restricted T cells are critically important for regulation of the spontaneous disease process in NOD mice.

MeSH Terms
Animals Antigens, CD1/genetics Antigens, CD1d Chromosome Mapping Diabetes Mellitus/etiology Female Immunologic Memory Killer Cells, Natural/physiology Mice Mice, Inbred C57BL Mice, Inbred NOD Mice, SCID Receptors, CCR4 Receptors, CCR5/analysis Receptors, Chemokine/analysis Th1 Cells/physiology Th2 Cells/physiology
Chemicals
Antigens, CD1 Antigens, CD1d Ccr4 protein, mouse Receptors, CCR4 Receptors, CCR5 Receptors, Chemokine
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Shi F D
Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Flodstrom M
Balasa B
Kim S H
Van Gunst K
Strominger J L
Wilson S B
Sarvetnick N
References (31)
31 references, click to expand
  1. Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.
    Immunol Rev. 1999 Jun;169:55-65 PMID: 10450508
  2. The NOD mouse model of type 1 diabetes: as good as it gets?
    Nat Med. 1999 Jun;5(6):601-4 PMID: 10371488
  3. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.
    J Exp Med. 1999 Oct 4;190(7):963-72 PMID: 10510086
  4. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    J Immunol. 1999 Nov 1;163(9):4647-50 PMID: 10528160
  5. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.
    J Exp Med. 1999 Nov 1;190(9):1215-26 PMID: 10544194
  6. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells.
    Eur J Immunol. 2000 Apr;30(4):985-92 PMID: 10760785
  7. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Immunity. 2000 Apr;12(4):431-40 PMID: 10795741
  8. Regulatory T cells in autoimmmunity*.
    Annu Rev Immunol. 2000;18:423-49 PMID: 10837065
  9. The temporal importance of TNFalpha expression in the development of diabetes.
    Immunity. 2000 May;12(5):459-69 PMID: 10843379
  10. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes.
    Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7411-6 PMID: 10840051
  11. CD1-restricted T-cell responses and microbial infection.
    Nature. 2000 Aug 17;406(6797):788-92 PMID: 10963609
  12. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations.
    J Immunol. 2000 Sep 15;165(6):3105-10 PMID: 10975823
  13. NKT cells: facts, functions and fallacies.
    Immunol Today. 2000 Nov;21(11):573-83 PMID: 11094262
  14. Mapping and identification of autoimmunity genes.
    Curr Opin Immunol. 2000 Dec;12(6):691-7 PMID: 11102774
  15. Chemokines, chemokine receptors and hematopoiesis.
    Immunol Rev. 2000 Oct;177:150-74 PMID: 11138773
  16. Natural killer cells determine the outcome of B cell-mediated autoimmunity.
    Nat Immunol. 2000 Sep;1(3):245-51 PMID: 10973283
  17. Innate immunity and autoimmunity: from self-protection to self-destruction.
    Trends Immunol. 2001 Feb;22(2):97-101 PMID: 11286711
  18. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.
    Cell. 1988 Mar 11;52(5):773-82 PMID: 2449974
  19. The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms.
    J Exp Med. 1993 Jan 1;177(1):155-64 PMID: 8418197
  20. Following a diabetogenic T cell from genesis through pathogenesis.
    Cell. 1993 Sep 24;74(6):1089-100 PMID: 8402882
  21. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    Nature. 1993 Nov 4;366(6450):69-72 PMID: 7694152
  22. Genetic control of autoimmune diabetes in the NOD mouse.
    Annu Rev Immunol. 1995;13:179-200 PMID: 7612220
  23. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
    J Immunol. 1996 May 15;156(10):4035-40 PMID: 8621946
  24. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4.
    Immunity. 1997 Apr;6(4):469-77 PMID: 9133426
  25. Mechanism underlying counterregulation of autoimmune diabetes by IL-4.
    Immunity. 1997 Sep;7(3):411-8 PMID: 9324361
  26. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.
    Nature. 1998 Jan 8;391(6663):177-81 PMID: 9428763
  27. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.
    Immunity. 1997 Dec;7(6):727-38 PMID: 9430219
  28. Genetic control of diabetes progression.
    Immunity. 1997 Dec;7(6):873-83 PMID: 9430232
  29. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    J Exp Med. 1998 Apr 6;187(7):1047-56 PMID: 9529321
  30. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.
    J Exp Med. 1998 Nov 16;188(10):1831-9 PMID: 9815260
  31. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    J Immunol. 1999 Sep 1;163(5):2960-8 PMID: 10453045
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2001-06-05
Pages
6777-82
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC34429
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]